Last updated on June 2019

A Study to Evaluate the Efficacy Safety and Pharmacokinetics of UTTR1147A Compared With Placebo and With Vedolizumab in Participants With Moderate to Severe Ulcerative Colitis (UC)


Brief description of study

This study is designed to evaluate the efficacy, safety, and pharmacokinetics of UTTR1147A compared with vedolizumab and with placebo in the treatment of participants with moderate to severe UC. This study will consist of two parts, Part A and Part B. Part A will test the induction of clinical remission and Part B will test the durability of clinical remission.

Clinical Study Identifier: NCT03558152

Find a site near you

Start Over

QWay Research

Hialeah, FL United States
1.74miles
  Connect »

LCC Medical Research Institute

Miami, FL United States
5.68miles
  Connect »

University of Miami

Miami, FL United States
6.73miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.